Last update:

HIV & AIDS news

HIV & AIDS

International AIDS relief program, at 20, looks to next steps

Saturday marks a major milestone in the global fight to eliminate the AIDS epidemic, as the U.S. President's Emergency Plan for AIDS Relief celebrates its 20th anniversary as the largest commitment by a country to combat ...

Medical research

Tiny ion is crucial for HIV replication, say chemists

A study by chemists at the University of Chicago has uncovered a new key step in the process that HIV uses to replicate itself.

HIV & AIDS

Scientists find potential cellular target for HIV therapies

Researchers at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology have discovered a protein that appears to play a key role in helping HIV replicate in human immune cells, providing more clues ...

Medications

FDA approves Sunlenca for treatment-resistant HIV

The U.S. Food and Drug Administration has approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with HIV-1 whose HIV infection cannot be successfully treated with other available ...

HIV & AIDS

Task force recommends PrEP for reducing risk for HIV acquisition

The U.S. Preventive Services Task Force (USPSTF) recommends preexposure prophylaxis (PrEP) for reducing the risk for HIV infection among individuals at increased risk for HIV acquisition. This recommendation forms the basis ...

HIV & AIDS

Recommendations updated for treatment, prevention of HIV

In a special communication article published online Dec. 1 in the Journal of the American Medical Association, the International Antiviral Society-USA Panel presents updated recommendations for the use of antiretroviral drugs ...

HIV & AIDS

Scientists may be closer to effective HIV vaccine

It's thought that for an HIV vaccine to be widely effective, it will have to spur the body to make special antibodies that can neutralize a broad range of HIV strains. Now scientists say they have taken an essential step ...

HIV & AIDS

HIV infection leaves a 'memory' in cells

Though antiretroviral therapy has made HIV a manageable disease, people living with HIV often suffer from chronic inflammation. This can put them at an increased risk of developing comorbidities such as cardiovascular disease ...

HIV & AIDS

Study identifies how stealthy HIV evades drugs and immunity

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health ...

HIV & AIDS

Chronic 'jet lag' discovered in people living with HIV

People living with HIV have a significantly delayed internal body clock, consistent with the symptoms of jet lag, according to new findings reported by researchers from universities in South Africa and the U.K.

HIV & AIDS

A better understanding of how HIV-1 evades the immune system

The type of virus used as a model to study the efficacy of non-neutralizing antibodies against the virus responsible for AIDS has a crucial role to play, according to a new study led by Andrés Finzi, Université de Montréal ...

HIV & AIDS

Therapeutic HIV vaccine achieves encouraging results

A phase I/IIa clinical trial that the University of Oxford collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was ...

HIV & AIDS

People with untreated HIV being hit hardest by monkeypox

While monkeypox cases are declining in the United States, a new government report shows that patients with weakened immune systems, especially those living with HIV, have been hit particularly hard by the virus.